CN104758663A - External-use liniment used for varicosity and application thereof - Google Patents

External-use liniment used for varicosity and application thereof Download PDF

Info

Publication number
CN104758663A
CN104758663A CN201510105933.1A CN201510105933A CN104758663A CN 104758663 A CN104758663 A CN 104758663A CN 201510105933 A CN201510105933 A CN 201510105933A CN 104758663 A CN104758663 A CN 104758663A
Authority
CN
China
Prior art keywords
parts
radix
herba
liniment
cortex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510105933.1A
Other languages
Chinese (zh)
Inventor
贾学亮
贾瑞雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510105933.1A priority Critical patent/CN104758663A/en
Publication of CN104758663A publication Critical patent/CN104758663A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to an external-use liniment used for varicosity and an application thereof. The external-use liniment is prepare from following raw materials: rhizome chuanxiong, astragalus membranaceus, cortex phellodendri, spina gleditsiae, red peony roots, loofah sponge, folium isatidis, flos carthami, herba epimedii, ligustrum lucidum ait, poria cocos, dandelion, herba houttuyniae, cortex magnoliae officinalis, achyranthes bidentata, radix clematidis, kusnezoff monkshood roots, frankincense, myrrh, honey suckles, cassia twigs, oldenlandia diffusa, rhizome imperata cylindrica, dried root bark of mulberry trees, spina date seeds, semen cuscutae, monkshoods and liquorice. The medicine composition is strict in formula, is simple in preparation, is definite in curative effects aiming to the varicosity and has a wide prospect.

Description

For cirsoid externally applied liniment and application thereof
Technical field
The invention belongs to Chinese medicine technical field, concrete, relating to a kind of is that raw material is for cirsoid externally applied liniment and application thereof with Chinese herbal medicine.
Background technology
Varicosis refers to that the vein caused is tortuous, expansion due to factors such as blood stasis, vein tube wall weaknesses.All can there is varicose in the vein at the multiple position of health, such as hemorrhoid are exactly a kind of varicosis in fact, clinical visible esophagus fundus ventricularis varication, varicocele and abdominal wall varicosis etc. in addition.The position that varicosis the most often occurs is at lower limb.It is emphasized that varicosis itself may be the secondary manifestation of other pathological changes, as inaccessible in caval vein etc., answer positive treatment protopathy.Varicose veins of the lower extremity be patient's lower limb tube wall become book, superficial vein is thicker, in Lumbricus shape or lumps be the main manifestations of varicose veins of the lower extremity.The many superficial vein blood flow reflux caused due to superficial vein first pair of valvular insufficiency of the cause of disease, increase veins of lower extremity pressure and cause.Secondly, geneogenous wall of vein weakness is also major reason, and patient is often associated with the whole body or circumscribed wall of vein defect, when vein pressure increases, just produces tortuous, the expansion of vein.Finally, stand for a long time, fat and abdominal pressure etc. because of procatarxis can increase that vein pressure all can increase that varicosis development occurs may.
Varicosis morbidity is early stage, mostly is the lower limb swollen discomfort of acid and dull pain sense, has limbs sense of heaviness simultaneously, easily weak.How above-mentionedly behind station for a long time feel to increase the weight of, then can be alleviated by flat sleeping, limb lifting.Pathological changes middle and late stage, wall of vein is impaired, vein protuberance, expansion, tortuous, in Lumbricus sample outward appearance, with the traveling of medial leg great saphenous vein, district is obvious.Course of disease elder, limb skin then occurs that trophism changes, and as desquamation, pruritus, pigmentation etc., even forms eczema and ulcer.Along with the differentiation of the state of an illness, can with the symptom such as pain, lower extremity swelling and distension, stasis dermatitis, superficial vein thrombosis of blood vessel traveling.
Motherland's medical science thinks that varicosis belongs to the BI-syndrome involved the blood vessels category of the traditional Chinese medical science, is referred to as nodular varicosity, and merging eczema claims eczema, merging ulcer claims ecthyma.Now how weak owing to wall of vein, pressure rising etc. in vein valve defect and superficial vein.Varicose veins of the lower extremity is one of surgical common disease, and prevalence is very large in various countries' difference.The sickness rate of many American-European countries is up to 20%-40%, and in China, Zhang Peihua etc. investigate in more than 15 years old crowd, and sickness rate is 8.16%, and more than 45 years old is 16.4%, calculates existing patient about 8,000 ten thousand to 1 hundred million example.Varicose veins of the lower extremity is common with great saphenous vein, and independent varix of small saphenous vein is more rare, occurs the complication such as superficial thrombophlebitis, ulcer, variceal bleeding time serious.In the cause of disease, the traditional Chinese medical science think work and rest excessively, internal injury caused by excess of seven emotions, eating and drinking without temperance and cause healthy energy interior-deficiency, cause the stasis of blood because of void; Doctor trained in Western medicine think stand for a long time, heavy physical labour, habitual constipation, obesity etc. make valve lobe leaf bear pulling property of support pressure, with the passing of time thinning elongation and prolapsing, and cause valve insufficiency.The traditional Chinese medical science take void as primary disease basic reason, pathogenesis is summed up as the raw expectorant of the deficiency of vital energy, essential resistance of turbid phlegm, blood stagnancy due to deficiency of QI becomes the stasis of blood, stasis blocking venation, and different stages of development doublely can be shown in again the different pathogenesis change such as noxious dampness, damp and hot, cold-damp, and the side's of sending medication is carried out on determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs basis, the traditional Chinese medical science has better motility and specific aim compared with the therapy such as simple doctor trained in Western medicine antiinflammatory, intravenous injection medicine, operation, and toxic and side effects is little, is applicable to prolonged application.But often there is the inapparent problem of curative effect in Chinese traditional treatment.Therefore, invention one effectively can treat varicosis, and toxic and side effects is little, and the Chinese medicine for external application being applicable to prolonged application has great importance.
Summary of the invention
Object of the present invention is exactly to solve problems of the prior art, in conjunction with the integrated Empirical formula of forefathers, according to doctor's row practice for many years, by the research to Chinese medicine, and in conjunction with dialectical demonstration, in many ways the length of many families is collected, seek therapeutic regimen, according to research, inventor thinks that varicose veins of the lower extremity belongs to the traditional Chinese medical science " BI-syndrome involved the blood vessels ", categories such as " superficial obstructive phlebitis ", primary disease is because natural endowment is not enough, muscle arteries and veins is weak, in addition walking for a long time standing for a long time, overworked, further damage muscle arteries and veins, so that passages through which vital energy circulates does not conform to, QI-blood circulation is not smooth, blood stop up under, the expansion of congestion retardance venation is full, with the passing of time staggeredly tortuously to form, or deficiency of vital energy cold coagulation to cause the capable operation of gas not smooth, qi stagnation hemagglutination, stasis blocking blood vessels meridians, the stasis of blood is obstructed for a long time, ischemia ulceration infects, notably recurrent exerbation.Treatment according to state of an illness determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, should take the method for blood circulation promoting and blood stasis dispelling, promoting the flow of QI in the collateral by warming the meridian.It is rapid-action in pharmaceutical preparation of the present invention, effect is strong, short treating period, easy to use, without obvious toxic-side effects, to varicosis determined curative effect.
For achieving the above object, the technical solution used in the present invention is as follows:
One is used for the treatment of cirsoid pharmaceutical composition, and it is prepared by following raw material and obtains:
Rhizoma Chuanxiong, the Radix Astragali, Cortex Phellodendri, Spina Gleditsiae, Radix Paeoniae Rubra, Retinervus Luffae Fructus, Folium Isatidis, Flos Carthami, Herba Epimedii, Fructus Ligustri Lucidi, Poria, Herba Taraxaci, Herba Houttuyniae, Cortex Magnoliae Officinalis, Radix Achyranthis Bidentatae, Radix Clematidis, Radix Aconiti Kusnezoffii, Olibanum, Myrrha, Flos Lonicerae, Ramulus Cinnamomi, Herba Hedyotidis Diffusae, Rhizoma Imperatae, Cortex Mori, Semen Ziziphi Spinosae, Semen Cuscutae, Radix Aconiti Lateralis Preparata, Radix Glycyrrhizae.
Preferably, pharmaceutical composition of the present invention is prepared by the raw material of following weight proportioning and obtains:
Rhizoma Chuanxiong 35 parts, the Radix Astragali 35 parts, Cortex Phellodendri 35 parts, Spina Gleditsiae 35 parts, Radix Paeoniae Rubra 30 parts,
Retinervus Luffae Fructus 30 parts, Folium Isatidis 30 parts, 30 parts, Flos Carthami, Herba Epimedii 30 parts, Fructus Ligustri Lucidi 28 parts,
28 parts, Poria, Herba Taraxaci 28 parts, Herba Houttuyniae 25 parts, Cortex Magnoliae Officinalis 25 parts, Radix Achyranthis Bidentatae 25 parts,
Radix Clematidis 25 parts, Radix Aconiti Kusnezoffii 25 parts, Olibanum 20 parts, Myrrha 20 parts, Flos Lonicerae 20 parts,
Ramulus Cinnamomi 20 parts, Herba Hedyotidis Diffusae 15 parts, Rhizoma Imperatae 15 parts, Cortex Mori 15 parts, Semen Ziziphi Spinosae 10 parts,
Semen Cuscutae 10 parts, Radix Aconiti Lateralis Preparata 10 parts, 10 parts, Radix Glycyrrhizae.
The preparation method of described pharmaceutical composition is:
1) each raw material is taken, for subsequent use;
2) Rhizoma Chuanxiong, Spina Gleditsiae, Herba Epimedii, Poria, Herba Houttuyniae, Cortex Magnoliae Officinalis, Radix Clematidis, Herba Hedyotidis Diffusae, Rhizoma Imperatae, Cortex Mori, Semen Cuscutae, Radix Aconiti Lateralis Preparata mix homogeneously is got, add the ethanol relative to mixture 2-3 times weight 75%, reflux, extract, 2 times, each 1 hour, extracting solution merges, and is concentrated into the clear paste (80 DEG C) that density is 1.2g/ml;
3) get the water intense fire that residual components adds 5 times of weight to boil, then slow fire boiling 1 hour, collecting by filtration filtrate and filtering residue; In filtering residue, add water, not have filtering residue to be as the criterion, intense fire boiled, then slow fire boiling 1 hour, collecting by filtration filtrate; Merge above-mentioned twice filtrate, after cooling, be condensed into the extractum (80 DEG C) that density is 1.2g/ml;
4) by step 1) and step 2) clear paste prepared merges, and stir, then preparation process makes different pharmaceutical preparation routinely.
Described pharmaceutical preparation is oral formulations or external preparation;
Preferably, the preparation method of external preparation is, adds the glycerol of sorbitol relative to clear paste weight 10% and 12%, is heated to 80 DEG C, prepares complex A;
Separately get and be heated to 80 DEG C relative to the stearic acid of clear paste weight 8%, the Yellow Vaselin of 3%, the lanoline of poly-Pyrusussuriensis fat 80,2% of 8% and the sucrose stearate of 1%, make melting, with complex A mixing and emulsifying 15 minutes, 80 DEG C are incubated 30 minutes, add the benzoic acid of 0.6% relative to clear paste weight and the ethyl hydroxybenzoate mixing of 0.15%, to obtain final product.
The component of medicine of the present invention all adopts natural raw material of Chinese medicine, and its preparation is easy, and medicine source is extensive, and with low cost, it follows the prescriptions principle of the traditional Chinese medical science, reliably evident in efficacy to varicosis, mild in medicine property and, there is not toxic and side effects, have a extensive future.
Detailed description of the invention
Embodiment 1
One is used for the treatment of cirsoid pharmaceutical composition, and it is prepared by the raw material of following weight proportioning and obtains:
Rhizoma Chuanxiong 35 parts, the Radix Astragali 35 parts, Cortex Phellodendri 35 parts, Spina Gleditsiae 35 parts, Radix Paeoniae Rubra 30 parts,
Retinervus Luffae Fructus 30 parts, Folium Isatidis 30 parts, 30 parts, Flos Carthami, Herba Epimedii 30 parts, Fructus Ligustri Lucidi 28 parts,
28 parts, Poria, Herba Taraxaci 28 parts, Herba Houttuyniae 25 parts, Cortex Magnoliae Officinalis 25 parts, Radix Achyranthis Bidentatae 25 parts,
Radix Clematidis 25 parts, Radix Aconiti Kusnezoffii 25 parts, Olibanum 20 parts, Myrrha 20 parts, Flos Lonicerae 20 parts,
Ramulus Cinnamomi 20 parts, Herba Hedyotidis Diffusae 15 parts, Rhizoma Imperatae 15 parts, Cortex Mori 15 parts, Semen Ziziphi Spinosae 10 parts,
Semen Cuscutae 10 parts, Radix Aconiti Lateralis Preparata 10 parts, 10 parts, Radix Glycyrrhizae.
The preparation method of described pharmaceutical composition is:
1) each raw material is taken, for subsequent use;
2) Rhizoma Chuanxiong, Spina Gleditsiae, Herba Epimedii, Poria, Herba Houttuyniae, Cortex Magnoliae Officinalis, Radix Clematidis, Herba Hedyotidis Diffusae, Rhizoma Imperatae, Cortex Mori, Semen Cuscutae, Radix Aconiti Lateralis Preparata mix homogeneously is got, add the ethanol relative to mixture 2-3 times weight 75%, reflux, extract, 2 times, each 1 hour, extracting solution merges, and is concentrated into the clear paste (80 DEG C) that density is 1.2g/ml;
3) get the water intense fire that residual components adds 5 times of weight to boil, then slow fire boiling 1 hour, collecting by filtration filtrate and filtering residue; In filtering residue, add water, not have filtering residue to be as the criterion, intense fire boiled, then slow fire boiling 1 hour, collecting by filtration filtrate; Merge above-mentioned twice filtrate, after cooling, be condensed into the extractum (80 DEG C) that density is 1.2g/ml;
4) by step 1) and step 2) clear paste prepared merges, and stir, then preparation process makes different pharmaceutical preparation routinely.
The preparation method of external preparation is, adds the glycerol of sorbitol relative to clear paste weight 10% and 12%, is heated to 80 DEG C, prepares complex A;
Separately get and be heated to 80 DEG C relative to the stearic acid of clear paste weight 8%, the Yellow Vaselin of 3%, the lanoline of poly-Pyrusussuriensis fat 80,2% of 8% and the sucrose stearate of 1%, make melting, with complex A mixing and emulsifying 15 minutes, 80 DEG C are incubated 30 minutes, add and mix relative to the benzoic acid of clear paste 0.6% and the ethyl hydroxybenzoate of 0.15%, obtain paste agent.
Embodiment 2
One is used for the treatment of cirsoid pharmaceutical composition, and it is prepared by the raw material of following weight proportioning and obtains:
Rhizoma Chuanxiong 35 parts, the Radix Astragali 35 parts, Cortex Phellodendri 35 parts, Spina Gleditsiae 35 parts, Radix Paeoniae Rubra 30 parts,
Retinervus Luffae Fructus 30 parts, Folium Isatidis 30 parts, 30 parts, Flos Carthami, Herba Epimedii 30 parts, Fructus Ligustri Lucidi 28 parts,
28 parts, Poria, Herba Taraxaci 28 parts, Herba Houttuyniae 25 parts, Cortex Magnoliae Officinalis 25 parts, Radix Achyranthis Bidentatae 25 parts,
Radix Clematidis 25 parts, Radix Aconiti Kusnezoffii 25 parts, Olibanum 20 parts, Myrrha 20 parts, Flos Lonicerae 20 parts,
Ramulus Cinnamomi 20 parts, Herba Hedyotidis Diffusae 15 parts, Rhizoma Imperatae 15 parts, Cortex Mori 15 parts, Semen Ziziphi Spinosae 10 parts,
Semen Cuscutae 10 parts, Radix Aconiti Lateralis Preparata 10 parts, 10 parts, Radix Glycyrrhizae.
The preparation method of described pharmaceutical composition is:
1) each raw material is taken, for subsequent use;
2) Rhizoma Chuanxiong, Spina Gleditsiae, Herba Epimedii, Poria, Herba Houttuyniae, Cortex Magnoliae Officinalis, Radix Clematidis, Herba Hedyotidis Diffusae, Rhizoma Imperatae, Cortex Mori, Semen Cuscutae, Radix Aconiti Lateralis Preparata mix homogeneously is got, add the ethanol relative to mixture 2-3 times weight 75%, reflux, extract, 2 times, each 1 hour, extracting solution merges, and is concentrated into the clear paste (80 DEG C) that density is 1.2g/ml;
3) get the water intense fire that residual components adds 5 times of weight to boil, then slow fire boiling 1 hour, collecting by filtration filtrate and filtering residue; In filtering residue, add water, not have filtering residue to be as the criterion, intense fire boiled, then slow fire boiling 1 hour, collecting by filtration filtrate; Merge above-mentioned twice filtrate, after cooling, be condensed into the extractum (80 DEG C) that density is 1.2g/ml;
4) by step 1) and step 2) clear paste prepared merges, stirs, be split in by clear paste on non-woven fabrics and can prepare patch, and the area of non-woven fabrics is 15 be multiplied by 10cm; Sharing dosage is the every block non-woven fabrics of 10g/.
Embodiment 3
Irritation test
Acute toxicity test:
20 rabbit are divided into 2 groups at random, often organize 10, male and female half and half, with 10% sodium sulfide to family's rabbit back depilation, unhairing area is about 150cm 2.The making of damaged skin adopts sterilization ferrum file to scratch (with oozing of blood degree of being), unguentum 1g prepared by the embodiment of the present invention 1 is applied respectively after unhairing, the patch sticking embodiment 2 preparation is also fixed with nonirritant adhesive plaster in depilation district, every animal sub-cage rearing, administration is after 24 hours 1, 24, 48, 72 is little of the 7th day, observe every day and record the body weight of animal, fur, gloss, diet, the change of eye and mucosa, respiratory center, nervous system, extremity activity and death condition, and put to death rabbit after Yu Qi, its heart of anatomic observation, liver, spleen, lung, the change of the internal organs such as kidney.
Result: the present invention prepares external preparation to the behavior of damaged skin rabbit, activity, diet, fur gloss, respiratory center, nervous system and body weight without any harmful effect, and none rabbit is dead.Rabbit is put to death, the main organs no abnormality seens such as its heart of anatomic observation, liver, spleen, lung, kidney after seven days.Therefore external preparation of the present invention does not all cause acute toxic reaction to rabbit on damaged skin.
Embodiment 3
Clinical data
The clinical patient collecting 116 routine varicose veins of the lower extremity altogether, is divided into 2 groups at random.Treatment group 58 example, man 34 example, female 24 example, age 27-51 year, course of disease 1-8; Matched group 58 example, man 32 example, female 26 example, age 26-50 year, course of disease 1.5-7.5.Two groups of Genders, ages compare with the course of disease, do not have significant difference, have comparability.
Diagnostic method
Two groups of patients all carry out the test of clinical great saphenous vein valvular function, color ultrasound examination, Deep venou Patency test and the test of communicating veins valvular function, all cases gets rid of congenital vascular malformation, deep vein thrombosis of lower extremity and Budd-Chairi syndrome etc. and primary deep venous valvular inadequacy patient.
Therapeutic Method
Treatment group: with cotton ball soaked in alcohol sterilization, remove the secretions on skin, uniform application liniment of the present invention (being prepared according to the method for embodiment 1), thickness is 1-2mm, covers one deck sliver, then covers sterile gauze, with adhesive plaster or the fixing wrapping of binder, prevent from coming off, change dressings every day 1 time.
Matched group vascular tablet for recovery, daily 3 times, each serving with 4.
All treat 1 month for two groups.
Statistical method, adopts SPSS18.0 statistics software data processing.
Therapeutic outcome
Efficacy evaluation method
Curative effect is divided into healing, part healing and recurrence 3 ranks: patient's naked eyes have no varicosis, fundamental symptoms disappears or is improved, without complication, target vein disappears for healing; The visible varicosis in a small amount of patient, fundamental symptoms disappear or improve, target vein segment is incompressible, segment section is inaccessible, caliber reduces reflux < 1s for part healing, patient's vein unchanged or comparatively treatment before situation increase the weight of, fundamental symptoms is unchanged or increase the weight of, and not closed through 2 months check target veins, caliber is unchanged, reflux >1s is recurrence.
Two groups of curative effects
After the treatment of month, two groups of therapeutic effect are as shown in table 1 below:
Table 1
Group Number of cases Cure Part is cured Recurrence Total effective rate
Treatment group 58 20 33 5 91.3%
Matched group 58 7 40 11 81%
Through statistical analysis, there is extremely significant difference in experimental group and matched group on clinical efficacy.
Embodiment 4
Model case
Thank certain, female, 48 years old, suffer from varicose veins of the lower extremity existing 3 years, both legs are just like " blue or green Serpentis " is wound around, and before treatment, the state of an illness is even more serious, little legs become numb when walking, send out heavy, distending pain, and having an injection, it is not remarkable to take medicine equal effect.Give patch prepared by embodiment 2, within 15 days, be a course for the treatment of, after two courses for the treatment of, clinical symptoms all disappears, and the state of an illness is fully recovered, and within 6 months, visits without bounce-back.
Zhang, 65, suffer from varicosis more than ten years, swelling is in recent years obvious, and skin color is dimmed purple gradually, and shank Zeng Yin occurs ulceration by after wound.Before treatment, main manifestations is left lower extremity swelling, and skin purple is black, and area is comparatively large, and the scleroma lump that feel is harder, Zu Xue district is mulberry, and diseased region skin temperature is higher than contralateral limbs.Patient's private prosecution is even has left lower extremity to generate heat, swell, and pain is not obvious.Give patch prepared by embodiment 2, within 15 days, be a course for the treatment of, after the treatment of 4 courses for the treatment of, lump dissipates substantially, and skin temperature is identical with offside, and Zu Xue district is dark violet also disappears the transference cures such as hot, swollen, pain substantially.Varicosis is cured, and clinical symptoms all disappears, and the state of an illness is fully recovered, and within 6 months, visits without bounce-back.
Above-mentioned each Chinese medicinal components that the present invention adopts makes compatibility mutually, its collaborative effect of curing the disease can be played, there is between each composition of raw material of Chinese medicine used drug effect be interweaved and mutually promote and coordinate usefulness, through clinical verification, have good therapeutic effect to varicosis, in the applicant's medical practice for many years, the case Numerous of curing, all obtains good effect, and with low cost, alleviate the burden of patient, have broad application prospects.

Claims (4)

1. for a cirsoid externally applied liniment, it is characterized in that, described liniment is prepared by following raw material and obtains:
Rhizoma Chuanxiong, the Radix Astragali, Cortex Phellodendri, Spina Gleditsiae, Radix Paeoniae Rubra, Retinervus Luffae Fructus, Folium Isatidis, Flos Carthami, Herba Epimedii, Fructus Ligustri Lucidi, Poria, Herba Taraxaci, Herba Houttuyniae, Cortex Magnoliae Officinalis, Radix Achyranthis Bidentatae, Radix Clematidis, Radix Aconiti Kusnezoffii, Olibanum, Myrrha, Flos Lonicerae, Ramulus Cinnamomi, Herba Hedyotidis Diffusae, Rhizoma Imperatae, Cortex Mori, Semen Ziziphi Spinosae, Semen Cuscutae, Radix Aconiti Lateralis Preparata, Radix Glycyrrhizae.
2. liniment according to claim 1, is characterized in that, described liniment is prepared by the raw material of following weight parts and obtains:
Rhizoma Chuanxiong 35 parts, the Radix Astragali 35 parts, Cortex Phellodendri 35 parts, Spina Gleditsiae 35 parts, Radix Paeoniae Rubra 30 parts,
Retinervus Luffae Fructus 30 parts, Folium Isatidis 30 parts, 30 parts, Flos Carthami, Herba Epimedii 30 parts, Fructus Ligustri Lucidi 28 parts,
28 parts, Poria, Herba Taraxaci 28 parts, Herba Houttuyniae 25 parts, Cortex Magnoliae Officinalis 25 parts, Radix Achyranthis Bidentatae 25 parts,
Radix Clematidis 25 parts, Radix Aconiti Kusnezoffii 25 parts, Olibanum 20 parts, Myrrha 20 parts, Flos Lonicerae 20 parts,
Ramulus Cinnamomi 20 parts, Herba Hedyotidis Diffusae 15 parts, Rhizoma Imperatae 15 parts, Cortex Mori 15 parts, Semen Ziziphi Spinosae 10 parts,
Semen Cuscutae 10 parts, Radix Aconiti Lateralis Preparata 10 parts, 10 parts, Radix Glycyrrhizae.
3. the liniment according to claim 1-2, is characterized in that, the preparation method of described liniment comprises the steps:
1) each raw material is taken according to weight portion, for subsequent use;
2) Rhizoma Chuanxiong, Spina Gleditsiae, Herba Epimedii, Poria, Herba Houttuyniae, Cortex Magnoliae Officinalis, Radix Clematidis, Herba Hedyotidis Diffusae, Rhizoma Imperatae, Cortex Mori, Semen Cuscutae, Radix Aconiti Lateralis Preparata is got, mix homogeneously, add the ethanol relative to mixture 2-3 times weight 75%, reflux, extract, 2 times, each 1 hour, extracting solution merges, and is concentrated into the clear paste that density is 1.2g/ml;
3) get surplus stock, the water intense fire adding 5 times of weight boils, then slow fire boiling 1 hour, collecting by filtration filtrate and filtering residue; In filtering residue, add water, not have filtering residue to be as the criterion, intense fire boiled, then slow fire boiling 1 hour, collecting by filtration filtrate; Merge above-mentioned twice filtrate, after cooling, be condensed into the extractum that density is 1.2g/ml;
4) by step 1) and step 2) clear paste prepared merges, stirs, be then prepared into liniment according to a conventional method.
4. liniment described in claim 1-3 is used for cirsoid purposes.
CN201510105933.1A 2015-03-11 2015-03-11 External-use liniment used for varicosity and application thereof Pending CN104758663A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510105933.1A CN104758663A (en) 2015-03-11 2015-03-11 External-use liniment used for varicosity and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510105933.1A CN104758663A (en) 2015-03-11 2015-03-11 External-use liniment used for varicosity and application thereof

Publications (1)

Publication Number Publication Date
CN104758663A true CN104758663A (en) 2015-07-08

Family

ID=53640983

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510105933.1A Pending CN104758663A (en) 2015-03-11 2015-03-11 External-use liniment used for varicosity and application thereof

Country Status (1)

Country Link
CN (1) CN104758663A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105797095A (en) * 2016-03-10 2016-07-27 李强 Traditional Chinese medicine external lotion for preventing and treating calf varicosity

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843676A (en) * 2010-04-28 2010-09-29 于洋 Chinese medicinal preparation for treating varicosity diseases and preparation method thereof
KR20140142765A (en) * 2013-06-04 2014-12-15 한경수 Food and pharmaceutical composition for preventing or improving thrombotic disease comprising extract of grape leaf as effective component

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843676A (en) * 2010-04-28 2010-09-29 于洋 Chinese medicinal preparation for treating varicosity diseases and preparation method thereof
KR20140142765A (en) * 2013-06-04 2014-12-15 한경수 Food and pharmaceutical composition for preventing or improving thrombotic disease comprising extract of grape leaf as effective component

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
符健等: "火针结合中药泡洗治疗下肢静脉曲张临床观察", 《内蒙古中医药》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105797095A (en) * 2016-03-10 2016-07-27 李强 Traditional Chinese medicine external lotion for preventing and treating calf varicosity

Similar Documents

Publication Publication Date Title
CN103520698B (en) A kind of medicine for the treatment of dysmenorrhea
CN102362919B (en) Traditional Chinese medicine for treating scleroderma
CN102600426B (en) Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof
CN101797335B (en) Chinese medicinal composition for treating functional uterine bleeding
CN103768531B (en) Chinese medicine composition being used for the treatment of rheumatoid arthritis and preparation method thereof
CN104906465A (en) Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof
CN102716334B (en) Chinese medicinal composition for dispelling the cold and removing stasis
CN103212037B (en) Traditional Chinese medicine for treating female endocrine disorder and preparation method of traditional Chinese medicine
CN104784538A (en) Chinese medicinal preparation for treating diabetes and preparation method
CN102198202B (en) Pills for treating gout
CN104398729A (en) Traditional Chinese medicine composition treating blood stasis type hemorrhoid
CN104758663A (en) External-use liniment used for varicosity and application thereof
CN103316239A (en) Traditional Chinese medicine for treating anaphylactoid purpura
CN102205067B (en) Traditional Chinese medicine composition for treating chronic urticaria
CN103330775A (en) Traditional Chinese medicine fuming composition used for treatment of varicose vein of lower limb
CN105456974A (en) Traditional Chinese medicine composition for treating congealing cold blood stasis adenomyosis
CN104740036A (en) Traditional Chinese medicine composition for treating Qi stagnation and blood stasis amenorrhea
CN104740582B (en) It is a kind of for the pharmaceutical preparation of puerperal blood clot dispersing and its application and detection method
CN103830684B (en) One treats menorrheal pharmaceutical composition and application thereof
CN104645139A (en) Traditional Chinese medicine pharmaceutical composition for treating varicosity and preparation technology thereof
CN103479914B (en) A kind of Chinese medicine oral liquid for the treatment of metrorrhagia
CN103432333B (en) Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism
CN105213810A (en) One treats cirsoid Chinese Traditional Medicines
CN105521391A (en) Traditional Chinese medicine for tonifying liver and kidney and for strengthening bones and muscles and preparation method of traditional Chinese medicine
CN104784619A (en) Traditional Chinese medicine for treating post-traumatic early limb swelling

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150708

RJ01 Rejection of invention patent application after publication